Summary
Lam Research Corporation (LRCX) filed an 8-K on April 22, 2020, primarily to announce its financial results for the fiscal quarter ended March 29, 2020. The filing also supplemented its risk factors, specifically addressing the adverse impact of the COVID-19 outbreak on its business, operations, and financial results. Investors should note that the information regarding financial results is furnished and not deemed "filed" for regulatory purposes. The company is acknowledging that the global pandemic and related containment measures have significantly disrupted its operations. This includes facility closures, production delays, supply chain disruptions, and challenges in staffing and business travel. These impacts are expected to lead to delays in shipments and product development, increased costs, and reduced revenue and profitability, with the potential for material adverse effects. The company also noted the broader economic uncertainty and potential impact on customer spending and ability to pay.
Key Highlights
- 1Lam Research announced its financial results for the fiscal quarter ended March 29, 2020, via a press release filed as Exhibit 99.1.
- 2The company is explicitly disclosing the adverse impacts of the COVID-19 outbreak on its business, operations, and financial results.
- 3COVID-19 related disruptions include facility closures, production delays, supply chain interruptions, and staffing challenges.
- 4These disruptions are expected to cause delays in product shipments and development, increase costs, and decrease revenue and profitability.
- 5The company acknowledges the difficulty in predicting the duration and ultimate impact of the pandemic on its business and the global economy.
- 6The filing also notes potential negative impacts on customer spending, ability to pay, and access to financing.
- 7Information regarding financial results is furnished, not deemed 'filed' for Section 18 liability.